A health ministry panel on Thursday approved two COVID-19 vaccines developed by Moderna Inc. and AstraZeneca Plc, clearing the way for Japan to boost supplies and speed up its sluggish inoculation program.The ministry is expected to give the formal green light for use in people aged 18 or older on Friday, bringing the number of vaccines available in the country to three, including the one already in use from Pfizer Inc.The Moderna vaccine is slated to be used at mass vaccination centers run by the Self-Defense Forces in Tokyo and Osaka as well as similar facilities being set up by some pref…READ FULL ARTICLE